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Introduction
Committed preadipocytes from mesenchymal stem cells differen-
tiate into mature adipocytes during adipogenesis [1]. In human
beings, formation of adipocytes begins during embryogenesis,
their number and size are substantially increased rapidly after birth
and contrary to the popular belief, adipogenesis occurs also in
adult adipose tissue throughout the life. The regulation of adipo-
genesis is crucial to maintain normal metabolic functions of the
body because both severely reduced adipose tissue, lipodystrophy
and an excess of adipose tissue, obesity, lead to profound meta-
bolic dysfunctions like insulin resistance [2].
Adipogenesis is a complex process that involves coordinated
expression and activation of two main groups of transcription factors,
peroxisome proliferator-activated receptor  (PPAR-)2 and CCAAT/
enhancer binding protein (C/EBP) family [3]. These transcription fac-
tors activate other transcription factors and several genes needed in
adipocyte maturation. As adipocytes differentiate, they acquire a spher-
ical and monolocular shape, insulin-responsive glucose uptake, a
coordinated control of lipid storage and utilization and a capability to
synthesize and secrete adipokines. Typical marker genes for mature
adipocytes are, e.g. glucose transporter 4 (Glut 4), fatty acid synthase
(FAS) and hormone-sensitive lipase (HSL) [4]. Glut 4 is the main
insulin-regulated glucose transporter isoform in mature adipocytes,
FAS catalyses one of the critical steps in triglyceride synthesis and HSL
functions as the rate-limiting enzyme in lipolysis by mediating the
hydrolysis of stored triacylglycerol to diacylglycerol.
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Abstract
Impaired adipogenesis has been shown to predispose to disturbed adipocyte function and development of metabolic abnormalities.
Previous studies indicate that polyamines are essential in the adipogenesis in 3T3-L1 fibroblasts. However, the specific roles of individual
polyamines during adipogenesis have remained ambiguous as the natural polyamines are readily interconvertible inside the cells. Here,
we have defined the roles of spermidine and spermine in adipogenesis of 3T3-L1 cells by using (S’)- and (R’)- isomers of -methylsper-
midine and (S,S’)-, (R,S)- and (R,R’)-diastereomers of ,-bismethylspermine. Polyamine depletion caused by -difluoromethylor-
nithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, prevented adipocyte differentiation by suppressing the expression
of its key regulators, peroxisome proliferator-activated receptor  and CCAAT/enhancer binding protein . Adipogenesis was restored
by supplementation of methylspermidine isomers but not of bismethylspermine diastereomers. Although both spermidine analogues
supported adipocyte differentiation only (S)-methylspermidine was able to fully support cell growth after extended treatment with -DFMO.
The distinction between the spermidine analogues in maintaining growth was found to be in their different capability to maintain func-
tional hypusine synthesis. However, the differential ability of spermidine analogues to support hypusine synthesis did not correlate with
their ability to support differentiation. Our results show that spermidine, but not spermine, is essential for adipogenesis and that the
requirement of spermidine for adipogenesis is not strictly associated with hypusine modification. The involvement of polyamines in the 
regulation of adipogenesis may offer a potential application for the treatment of dysfunctional adipocytes in patients with obesity and
metabolic syndrome.
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The naturally occurring polyamines, spermidine and spermine
and their precursor putrescine are required for normal cell growth
and differentiation. However, the role of polyamines and the mech-
anisms by which they are involved in cell differentiation depends
on the cell type. In several cell types (e.g. keratinocytes and chon-
drocytes), polyamines induce cell differentiation and maturation.
In other cell types, as in many tumour cells, differentiation process
is inhibited by polyamines [5]. It has been reported that
polyamines are essential during adipogenesis of 3T3-L1 cells and
increased cellular levels of spermidine are detected during adipo-
genesis [6, 7]. In addition, depletion of cellular polyamines by
treatment with a inhibitor of polyamine biosynthesis, -difluo-
romethylornithine (DFMO), has been noticed to prevent adipogen-
esis in 3T3-L1 by unknown mechanism and this inhibitory effect
of DFMO is reverted by supplementation of putrescine or spermi-
dine. However, specific roles of individual polyamines in adipoge-
nesis have remained ambiguous as the natural polyamines are
quickly metabolized further by the cells.
We have recently synthesized stable -methylated polyamine
analogues as single isomers and enantiomers: (S)- and (R)- iso-
mers of methylspermidine (MeSpd) and (S,S)- and (R,R )-
diastereomers of ,-bismethylspermine (Me2Spm). They are not
N-acetylated by spermidine/spermine N1-acetyltransferase (SSAT)
and MeSpd is a poor substrate for spermine synthase. Otherwise
these polyamine analogues seem to fulfil many of the physiologi-
cal roles of natural polyamines [8]. However, we have recently
shown that only (S )-MeSpd, but not (R)-MeSpd, can be converted
to hypusine in DU145 prostate carcinoma cells [9]. Hypusine is an
unusual amino acid which is an integral part of functional eukary-
otic translation initiation factor 5A (eIF5A) and is known to be
essential for normal cell growth [10]. Spermidine has been shown
to serve as the sole biosynthetic precursor in hypusine synthesis
[11]. In this paper, we have investigated the importance of individ-
ual polyamines in adipogenesis. Moreover, the possible role of
hypusinated eIF5A during adipogenesis was evaluated.
Materials and methods
Chemicals
The synthesis of (R)- and (S)-isomers of -MeSpd and (R,R )- and (S,S )-
enantiomers of ,-Me2Spm has been described earlier [12]. Insulin, 
3-isobuthyl-1-methylxanthine (IBMX), dexamethasone, aminoguanidine,
spermidine and spermine were purchased from (Sigma Aldrich, St. Louis,
MO, USA). The polyamine oxidase inhibitor MDL72527 [N,N-bis(2,3-buta-
dienyl)-1,4-butanediamine] was a generous gift from Hoechst-Roussel.
Cell cultures
3T3-L1 cells (CL-173) were purchased from American Type Culture
Collection (ATCC, Manassas, VA, USA). Cells were cultured in Dulbecco’s
modified Eagle’s medium (Gibco, Invitrogen, UK) supplemented with 10%
foetal bovine serum (Gibco) and 50 g/ml gentamycin. Cells were cultured
on 100 mm plates at 37C in 95% air and 5% carbon dioxide.
Throughout the adipogenesis experiments, 5 mM DFMO alone or in
combination with 100 M spermidine, spermine or polyamine analogues
was added to the medium at every medium change until harvest. Cultures
containing natural polyamines were supplemented with 1 mM aminoguani-
dine to inhibit polyamine degradation by serum-derived oxidases. Cells
were plated on six-well plates (80,000 cells/well) with the above-men-
tioned supplementation, cultured until confluence and then differentiated
into adipocytes as described earlier [13]. Briefly, 2 days after the conflu-
ence (differentiation day 0, 6 days after plating), cells were first grown in
medium supplemented with insulin, IBMX and dexamethasone for 48 hrs
whereafter (from differentiation day 2) in medium supplemented only with
insulin for the next 48 hrs. After that the medium was changed every other
day (on differentiation days 4 and 6). Long-term adipogenesis studies were
performed with 3, 5, 7 or 9 days subculture in the presence of 5 mM DFMO
and 100 M (R)- or (S )-MeSpd on 100 mm plates as a pre-treatment
before transferring cells to the six-well plates and induction of adipogene-
sis as described above. In all the experiments, cells were harvested on the
differentiation days 0, 4 and 8 by scraping the cells to buffer (25 mM Tris
pH 7.4, 1 mM DTT, 0.1 mM EDTA), sonicated and homogenized with a pes-
tle. For the cell proliferation studies, cells were plated on 100 mm plates
(250,000 cells/plate) or on six-well plates (45,000 cells/well) in the pres-
ence of 100 M polyamine analogues with or without 5 mM DFMO. Every
third day, cells were harvested by trypsinization, counted (Coulter particle
counter, Beckham, Fullerton, CA, USA) and passaged again, until day 12.
Analytical methods
Polyamines and their -methylated analogues were quantified by using high
performance liquid chromatography as described earlier [14]. Protein con-
centrations were determined by using Bradford Protein Assay Reagent
(BioRad Laboratories, Hercules, CA, USA). DNA contents were determined
by modified Burton’s method [15]. Different isoforms of eIF5A were analysed
by two-dimensional electrophoresis and immunoblotting as described earlier
[16, 17]. A total of 20 g of protein were used for each analysis. Samples
from the gels were blotted onto an Immobilon FL membrane (Millipore,
Billerica, MA, USA), probed with eIF5A antibody (BD Biosciences, San Jose,
CA, USA) and scanned with a Typhoon Variable Mode Imager (GE
Healthcare, Fairfield, CT, USA). Differentiation was evaluated by measuring
the accumulation of the fat by Oil Red O staining and detecting expression of
Glut 4 protein by Western blotting. Oil Red O staining was performed essen-
tially as described earlier [18] except that absorbance was measured in 
540 nm. Western blotting was performed according to a laboratory manual,
Current Protocols in Molecular Biology [19]. Shortly, 10 g of protein was
used for SDS-PAGE gel electrophoresis and transferred onto the PVDF mem-
branes. Membranes were blocked with 5% dry milk in phosphate-buffered
saline containing 0.1% Tween and probed with 1:10,000 dilution of Glut 4
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). HRP-conjugated
secondary antibody (Santa Cruz Biotechnology) was used in 1:10,000 dilu-
tion. Antibody-bound protein was detected by chemiluminescence reaction
(ECL Plus Western Blotting detection System, GE Healthcare).
Quantitative RT-PCR
The standard adipogenesis protocol was used as previously described. A
total of 5 mM DFMO alone or in combination with 100 M spermidine,
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spermine or polyamine analogues were added to the medium at every
medium change until harvested on the differentiation day 4. Total RNA
from 3T3L1 cells was isolated using Tri Reagent (Sigma Aldrich). Total
RNA was treated with DNA-free™ Kit (Applied Biosystems, Foster City,
CA, USA). The absence of genomic DNA in the RNA samples was verified
by a lack of PCR amplification with primers recognizing numerous Gapdh
pseudogenes. Total RNA was transcribed to cDNA using High Capacity
cDNA Archive kit (Applied Biosystems). Quantitative RT-PCRs were per-
formed with 12 ng (RNA equivalents) of cDNA as template, gene-specific
primers and probe, and Taqman reagents from Applied Biosystems in
ABI BRISM 7700 and 7000 (Applied Biosystems). Running conditions
were 2 min. at 50C, 10 min. at 95C and 40 cycles of 15 sec. at 95C and
1 min. at 60C. Primers and probes were designed using Assay-by-
Design system (Applied Biosystems). Data were normalized to
cyclophilin mRNA expression.
Statistical analyses
The data are expressed as the mean 	 S.D. One-way or two-way ANOVA
with Bonferroni’s post hoc test for multiple comparisons were used. A 
P-value less than 0.05 was considered significant. Analyses were performed
by using GraphPad Prism 4.03 software package (GraphPad Software,
Inc., San Diego, CA, USA).
Results
Effect of DFMO and polyamine analogues 
on adipogenesis
3T3-L1 cells were treated simultaneously with DFMO and
polyamine analogues in order to inhibit de novo polyamine synthe-
sis and to replace the natural polyamines with their methylated
counterparts, respectively. The intracellular concentrations of
polyamines and their analogues in cells treated with DFMO and
polyamine analogue isomers are presented in Table 1. DFMO treat-
ment depleted natural polyamines almost completely and only
remains of spermine were detected. High levels of spermidine and
spermine were detected in the untreated control cells and cells
treated with DFMO plus natural spermidine. Spermidine levels
were highest on the differentiation day 0 after which they declined
during differentiation. Spermine levels did not change significantly
during adipogenesis within given treatments. Cells exposed to
DFMO with (S)- or (R)-MeSpd contained very low levels of natu-
ral spermine, and traces of natural spermidine were detected only
with (S)-MeSpd treatment. Both isomers of MeSpd were metabo-
lized to some extent to monomethylated spermine. DFMO in com-
bination with either Me2Spm diastereomer depleted natural
polyamines completely. (S,S)-Me2Spm was slightly converted to
MeSpd, whereas (R,R)- Me2Spm was not.
Microscopic views of Oil Red O stained cells after 8 days of dif-
ferentiation are shown in Fig. 1. Untreated cells differentiated com-
pletely (Fig. 1A) whereas DFMO treatment totally prevented adipo-
genesis (Fig. 1B). DFMO-treated cells remained at confluent state
and maintained fibroblast-like appearance. In fact, they were
poorly visible in the phase contrast microscopy due to flatness of
the cells. Natural spermidine (not shown) and both (S)- and (R)-
MeSpd enabled the cells to differentiate in the presence of 5 mM
DFMO (Fig. 1C and D, respectively). Differentiated cells became
spherical in shape and they accumulated fat droplets in their cyto-
plasm. Contrary to spermidine isomers, (S,S)- and (R,R)-
Me2Spm did not support adipogenesis in the presence of DFMO
(Fig. 1E and F, respectively). Only very few cells had differentiated
whereas most of the cells remained at preadipocyte state.
In order to measure the amount of fat quantitatively, Oil Red O
stain was extracted from the cells and the absorbance of the
extracts was measured at 540 nm. Fat accumulation is presented
in Fig. 2. Cells treated with DFMO and (S)- or (R)-MeSpd accu-
mulated fat as well as the untreated control cells or cells treated
with DFMO and natural spermidine. If anything, accumulation of
fat in the cells treated with spermidine isomers was slightly
delayed when compared with the control cells on the differentia-
tion day 4. In contrast, the fat accumulation was significantly
decreased in the cells treated with DFMO and either (S,S)- or
(R,R)-Me2Spm. However, cells treated with the (S,S)-diastere-
omer accumulated fat somewhat better than the cells treated with
the (R,R)-diastereomer.
Differentiation was also assessed by quantifying the amount of
Glut 4 that is considered as a marker protein for mature
adipocytes. Results of Glut 4 protein expression supported those
from Oil Red O staining. On the differentiation day 4, the level of
Glut 4 protein was slightly lower in the cells treated with spermi-
dine isomers when compared with untreated control cells (Fig. 3).
On the differentiation days 6 and 8, equal amounts of Glut 4 were
expressed in the control cells and in cells treated with DFMO plus
(S)- or (R)-MeSpd. Cells treated with DFMO in combination with
Me2Spm diastereomers did not express Glut 4 protein at any time-
point (Fig. 3).
Hypusine is an integral part of functional eIF5A that is essential
for normal cell growth. As spermidine has been shown to serve as
the sole biosynthetic precursor in hypusine synthesis, the pres-
ence of hypusinated eIF5A and its precursor forms in differentiat-
ing 3T3-L1 cells were studied by using 2D electrophoresis and
immunoblotting (Fig. 4). Only hypusinated eIF5A was detected in
the untreated control cells on differentiation days 0 and 8.
Similarly, it was the prevalent form in the cells treated with DFMO
and natural spermidine or (S)-MeSpd. Treatment with DFMO and
(R)-MeSpd or either Me2Spm isomer only partially supported
hypusine synthesis leading to accumulation of precursor isoforms
of eIF5A. On differentiation day 8 some hypusinated eIF5A was
present when cells were treated with DFMO and (R)-MeSpd or
(S,S)-Me2Spm whereas it was barely detectable in cells treated
with DFMO and (R,R)-Me2Spm (Fig. 4).
The effect of natural spermine on adipogenesis in 3T3-L1 cells
was studied in similar conditions as described above. On differen-
tiation day 4, the cells treated with DFMO alone contained virtually
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Fig. 1 Morphological changes and fat
accumulation in 3T3-L1 cells after 8 days
of differentiation. During differentiation,
cells were untreated (A), treated with 
5 mM DFMO alone (B) or in combination
with 100 M (S)-MeSpd (C), (R)-MeSpd
(D), (S,S)-Me2Spm (E) or (R,R)-Me2Spm
(F). The cells were stained with Oil Red O
on the differentiation day 8. Scale bar, 
200 nm.
Table 1 Polyamine and analogue concentrations in 3T3-L1 cells. After plating, the cells were treated with 5 mM DFMO (D) and with 100 M 
spermidine or polyamine analogues throughout the experiment. The data, expressed as pmol/g DNA, are presented as the mean 	 S.D, n 
 3.
Control, untreated cells; nd., not detected
Put Spd MeSpd Spm MeSpm Me2Spm
Differentiation day 0
Control 59 	 6 400 	 35 nd. 69 	 11 nd. nd.
DFMO nd. nd. nd. 4 	 0.7 nd. nd.
DSpd nd. 478 	 39 nd. 62 	 5 nd. nd.
D(S)-MeSpd nd. nd. 589 	 106 22 	 5 109 	 2 nd.
D(R)-MeSpd nd. nd. 542 	 22 20 	 0.9 91 	 6 nd.
D(S,S)-Me2Spm nd. nd. 69 	 9 nd. nd. 506 	 82
D(R,R)-Me2Spm nd. nd. nd. nd. nd. 569 	 5
Differentiation day 4
Control nd. 183 	 19 nd. 98 	 17 nd. nd.
DFMO nd. nd. nd. 4 	 0.4 nd. nd.
DSpd 32 	 4 347 	 12 nd. 68 	 3 nd. nd.
D(S)-MeSpd nd. 0.7 	 1 500 	 17 11 	 0.5 8 	 0.2 nd.
D(R)-MeSpd nd. nd. 532 	 17 12 	 6 20 	 9 nd.
D(S,S)-Me2Spm nd. nd. 19 	 0.9 nd. nd. 301 	 22
D(R,R)-Me2Spm nd. nd. nd. nd. nd. 287 	 25
Differentiation day 8
Control 15 	 1 133 	 13 nd. 101 	 8 nd. nd.
DFMO nd. nd. nd. 2 	 0.2 nd. nd.
DSpd 19 	 0.6 240 	 12 nd. 67 	 3 nd. nd.
D(S)-MeSpd nd. 4.0 	 0.2 385 	 9 14 	3 12 	 1 nd.
D(R)-MeSpd nd. nd. 379 	 7 16 	 3 36 	 2 nd.
D(S,S)-Me2Spm nd. nd. 21 	 0.8 nd. nd. 251 	 22
D(R,R)-Me2Spm nd. nd. nd. nd. nd. 301 	 27
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no spermidine but a normal level of spermine (Table 2). Cells
treated with the combination of DFMO and spermine contained
spermine at concentrations twice as high as those found in
untreated or DFMO-treated cells. In addition, they contained sper-
midine at levels of about half of those in untreated cells at early
phase of differentiation (days 0 and 2) indicating some backcon-
version of spermine to spermidine. Adipogenesis was prevented in
DFMO-treated cells, as observed before, but it proceeded nearly
normally in cells supplemented with spermine. Parallel cultures
were additionally treated with 10 M MDL72527, an inhibitor of
polyamine oxidase and spermine oxidase (SMO), to prevent catab-
olism of spermine. With the addition of MDL72527, we were able
to deplete spermidine by day 4 and prevent the differentiation vir-
tually completely. The trace amount of spermidine, close to the
limit of detection, found at early phase of differentiation in cells
treated with DFMO, spermine and MDL72527 (Table 2) was not
sufficient to support differentiation, analogously to the situation
seen in cells treated with (S,S)-Me2Spm that was converted to
MeSpd to some extent (Table 1, Fig. 1).
Effect of long-term exposure to DFMO and
polyamine analogues on cell proliferation 
and differentiation of 3T3-L1 cells
We investigated the ability of polyamine analogues to maintain
cell proliferation of undifferentiated 3T3-L1 cells grown in the
absence or presence of 5 mM DFMO. Relative cell growth 
during a 12-day culture is depicted in Fig. 5. In the absence 
of DFMO (Fig. 5A), polyamine analogues did not dramatically
affect the cell growth. However, after 9 days with (R)-MeSpd or 
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Fig. 2 Fat accumulation in 3T3-L1 cells during adipogenesis. After plat-
ing, the cells were treated with 5 mM DFMO in combination with 100 M
spermidine or a polyamine analogue throughout the experiment. On the
differentiation days 0, 4 and 8 days cells were stained with Oil Red O
stain. For quantitative analysis of fat accumulation, Oil Red O stain was
extracted and quantified spectrophotometrically at 540 nm. The data,
expressed as absorbance per well, are presented as the mean 	 S.D., 
n 
 3, *** 
 P  0.001 as compared with untreated cells (Contr). S,
(S)-MeSpd, R, (R)-MeSpd, SS, (S,S)-Me2Spm, RR, (R,R)-Me2Spm.
Fig. 3 Expression of Glut 4 protein. After plating, the cells were untreated
(Cont) or treated with 5 mM DFMO in combination with 100 M spermi-
dine or a polyamine analogue. Glut 4 protein expression was determined
on differentiation days 4, 6 and 8. Ten micrograms of protein were used
for Western blotting analysis. Equal loading was confirmed by Ponceau
staining (not shown). Molecular size as kD is shown on the right. S, (S)-
MeSpd, R, (R)-MeSpd, SS, (S,S)-Me2Spm, RR, (R,R)-Me2Spm.
Fig. 4 Effect of MeSpd and Me2Spm isomers on the level of hypusinated
eIF5A in differentiating 3T3-L1 cells. During differentiation, cells were
untreated (control) or treated with 5 mM DFMO in combination with 
100 M (S)-MeSpd (S), (R)-MeSpd (R), (S,S)-Me2Spm (SS) or (R,R)-
Me2Spm (RR). Twenty micrograms of protein from each sample were
separated by two-dimensional gel electrophoresis followed by
immunoblotting and detection with eIF5A antibody.
1688
(R,R)-Me2Spm, cell growth was slower than that of the
untreated cells. DFMO treatment efficiently prevented cell growth
and a total growth arrest was obtained already at 6 days (Fig. 5B).
All used isomers of polyamine analogues were able to rescue
cells from DFMO-related growth inhibition at least to some
extent. (S)-MeSpd was the most effective and the only one that
maintained cell growth during the whole 12-day experiment. With
(R)-MeSpd and (S,S)-Me2Spm, the rate of cell growth was dra-
matically decreased during experiment. (R,R)-Me2Spm partially
rescued cells from growth inhibition for 6 days where after cell
proliferation ceased totally.
Long-term exposure to DFMO and (S)- or (R)-MeSpd isomers
was performed also to further study the utilization of spermidine
isomers in hypusine synthesis and the role of hypusination in adi-
pogenesis. In order to deplete cellular contents of natural spermi-
dine-derived hypusinated eIF5A before the induction of adipoge-
nesis, cells were pre-treated with DFMO and (S)- or (R)-MeSpd
for 3, 5, 7 or 9 days before plating. Results from all performed
experiments were similar and only the results from an experiment
with 3 days pre-treatment are presented here. Polyamine and
polyamine analogue concentrations are presented in Table 3.
Generally, levels of polyamines and polyamine analogues were
similar to those in the adipogenesis experiment without pre-treat-
ment (Table 1). As a difference, some natural spermidine was
detected and the level of natural spermine was substantially
decreased in cells treated with either MeSpd isomer (Table 3). All
cells treated with (S)-MeSpd grew and differentiated similarly to
the cells in previous experiments. In contrast, long-term treat-
ment with (R)-MeSpd affected cell growth and viability, and a
number of cells detached from plates and apparently died. Yet,
cells remaining on the plates differentiated and accumulated fat
as well as the (S)-MeSpd-treated cells. Therefore, fat accumula-
tion per well was higher in (S)-MeSpd-treated cells (Fig. 6A) but
when fat accumulation was normalized to DNA content represent-
ing cell number, (S)- and (R)-MeSpd-treated cells accumulated
fat equally (Fig. 6B). As in previous experiments, (S)-MeSpd-
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Table 2 Effect of MDL72527 on polyamine concentrations of the 
3T3-L1 cells treated with DFMO and natural spermine. After plating, the
cells were treated with 5 mM DFMO and 100 M spermine and/or 
20 m MDL72527 (MDL) as indicated throughout the experiment. The
data, expressed as pmol/g DNA, are presented as the mean 	 S.D., 
n 
 4. Control, untreated cells; nd., not detected
Put Spd Spm
Differentiation day 0
Control 14 	 5 234 	 17 72 	 13
DFMO nd. nd. 107 	 15
DFMO Spermine nd. 165 	 11 113 	 10
DFMO MDL  Spermine nd. 50 	 16 237 	 20
Differentiation day 1
Control nd. 340 	 20 83 	 4
DFMO nd. nd. 105 	 19
DFMO Spermine nd. 150 	 10 135 	 13
DFMO MDL  Spermine nd. 45 	 9 195 	 19
Differentiation day 4
Control 19 	 2 413 	 20 137 	 5
DFMO nd. nd. 96 	 34
DFMO Spermine nd. 57 	 3 226 	 19
DFMO MDL  Spermine nd. nd. 247 	 14 Fig. 5 Effect of MeSpd and Me2Spm isomers on cell proliferation of 3T3-
L1 cells in the presence or absence of DFMO. Cells were cultured in the
absence or presence of 100 M polyamine analogue without (A) or with
(B) 5 mM DFMO. The cells were harvested, counted and passaged every
third day until day 12. The data, expressed as increase in cell number per
well relative to untreated cultures (Contr), are presented as the mean 	
S.D., n 
 3. *, P  0.05, **, P  0.01 and ***, P  0.001 as compared
with untreated cells. S, (S)-MeSpd, R, (R)-MeSpd, SS, (S,S)-Me2Spm,
RR, (R,R)-Me2Spm.
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treated cells had only hypusinated eIF5A and (R)-MeSpd-treated
cells contained both the hypusinated form and precursor iso-
forms of eIF5A (results not shown).
Effects of DFMO, polyamine analogues and 
natural polyamines on expression of adipocyte
specific genes
To determine the mechanism(s) via which DFMO and polyamine
analogues contribute to adipogenesis, gene expression studies
were performed. As Fig. 7 shows, DFMO treatment blocked almost
completely expression of PPAR- and C/EBP-, the critical factors
regulating adipogenesis, on the differentiation day 4. Expression
of PPAR- in cells treated with (S)-MeSpd, (R)-MeSpd or natural
spermine was reduced about 30 to 40% whereas in cells treated
with (S,S)-Me2Spm, (R,R)-Me2Spm or natural spermine plus
MDL72527, a decline in the expression was about 70–80% 
(Fig. 7). In contrast, natural spermidine sustained the expression
of this transcription factor at the control level. Expression of
C/EBP- in cells treated with (S)-MeSpd, (R)-MeSpd or natural
spermidine was near to the control level whereas treatment 
with (S,S)-Me2Spm, (R,R)-Me2Spm or natural spermine plus
MDL72527 resulted in about 90% reduction in the expression. In
contrast, cells treated with natural spermine without MDL72527
exhibited about 55% reduced expression of C/EBP-. A similar
expression pattern between the treatments was also observed for
a lipolytic gene, HSL, and a late adipocyte differentiation marker,
FAS, on the differentiation day 4 (Fig. 7). The only exception was
that (R)-MeSpd -treated cells, similarly to (S,S)-Me2Spm, (R,R)-
Me2Spm and natural spermine plus MDL72527 -treated cells, had
dramatically reduced expression of FAS.
© 2009 The Authors
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Put Spd -MeSpd Spm -MeSpm
Differentiation day 0
Control 26 	 5 240 	 22 nd. 47 	 7 nd.
D(S)-MeSpd nd. 15 	 2 412 	 17 2 	 0.2 20 	 0.6 
D(R)-MeSpd nd. 12 	 3 383 	 14 0.1 	 0.1 38 	 7
Differentiation day 4
Control 27 	 8 238 	 12 nd. 137 	 2 nd.
D(S)-MeSpd nd. 4 	 2 524 	 37 2 	 2 24 	 4
D(R)-MeSpd nd. 4 	 0.7 452 	 19 0.4 	 0.4 34 	 2
Differentiation day 8
Control 34 	 1 179 	 6 nd. 129 	 4 nd.
D(S)-MeSpd nd. 3 	 0.6 424 	 11 4 	 0.1 25 	 2
D(R)-MeSpd nd. 6 	 0.5 358 	 9 0.4 	 0.6 42 	 5
Table 3 Polyamine and analogue concentrations in 3T3-L1 cells during differentiation after extended pre-treatment with DFMO and polyamine 
analogues. Cells were treated 3 days before, and during differentiation with 5 mM DFMO and 100 M MeSpd analogues. The data, expressed as
pmol/g DNA, are presented as the mean 	 S.D., n 
 3. Control, untreated cells; nd., not detected
Fig. 6 Fat accumulation in 3T3-L1 cells during differentiation after
extended pre-treatment with DFMO and polyamine analogues. Cells were
pre-treated for 3 days before plating and thereafter during differentiation
with 5 mM DFMO in combination with 100 M (S)- or (R)-MeSpd. On the
differentiation days 0, 4 and 8 days, the cells were stained with Oil Red
O. For quantitative analysis of fat accumulation, Oil Red O was extracted
and quantified spectrophotometrically at 540 nm. The data, expressed as
relative absorbance per well (A) or per DNA (B), are presented as the
mean 	 S.D., n 
 3. **, P  0.01 and ***, P  0.001 as compared with
untreated cells. S, (S)-MeSpd, R, (R)-MeSpd.
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Discussion
Obesity is a growing epidemic worldwide. During positive caloric
intake, excess fat is stored in adipocytes which are increased by their
size (hyperplasia) and number (hypertrophy) [2]. If normal adipoge-
nesis is disturbed, excess fat is stored through adipocyte hypertrophy.
Exceeding of the storage capacity of adipocytes causes dysfunction of
the adipocytes and accumulation of fat in non-adipose tissues which
in turn leads to the development of insulin resistance and metabolic
syndrome. Therefore, a direct reduction of adipogenesis does not
seem to have a beneficial effect on metabolism. In fact, it has been
noted that PPAR- agonists thiazolidinediones, are able to increase
recruitment, proliferation and differentiation of preadipocytes leading
ultimately to improved adipose tissue function and control of glucose
homeostasis [20]. Thus, it is important to delineate factors that sup-
port adipocyte differentiation, growth and metabolism.
In adipogenesis, the timely concerted action of different tran-
scription factors facilitates the differentiation of preadipocytes to
fully mature adipocytes. The exact role of polyamines, spermi-
dine in particular, in this process has remained unclear. Here, we
were able to confirm by using methylated polyamine analogues
that spermidine is the key polyamine for adipogenesis to occur,
as was previously suggested [6, 7]. In present study spermidine
and its -methylated analogues (S)-MeSpd or (R)-MeSpd were
able to rescue the cells from DFMO induced differentiation block-
age and the cells accumulated fat and expressed a mature
adipocyte marker, Glut4, like the control cells. In contrast, the
cells treated with either (S,S)-Me2Spm or (R,R)-Me2Spm iso-
mers together with DFMO showed markedly reduced differentia-
tion capability. Moreover, the inability of added natural spermine
to support adipogenesis was verified in conditions where forma-
tion of spermidine both via de novo synthesis and conversion
from spermine was prevented.
© 2009 The Authors
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Fig. 7 Effects of DFMO, polyamine analogues and natural polyamines on expression of adipocyte-specific genes. Results are presented relative to the
expression level in untreated cells (control, dashed line). Cells were cultured in the presence of 100 M polyamine or analogue with or without 5 mM
DFMO (D) and collected on the differentiation day 4. A total of 20 M MDL72527 (MDL) were added into a set of cells treated with DFMO and spermine
to prevent the backconversion of spermine to spermidine. The expression of selected genes was analysed by quantitative RT-PCR. Data are means 	 S.D.
of four cultures per group. *, P  0.05, **, P  0.01 and ***, P  0.001 as compared with untreated cells. PPAR-, peroxisome proliferator-activated
receptor ; C/EBP-, CCAAT/enhancer binding protein ; HSL, hormone-sensitive lipase and FAS, fatty acid synthase. S, (S)-MeSpd, R, (R)-MeSpd, SS,
(S,S)-Me2Spm, RR, (R,R)-Me2Spm.
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To address the question of the role of spermidine in adipogen-
esis, we studied the presence of hypusinated eIF5A in analogue-
treated cells during differentiation. In the present study, we did not
achieve complete depletion of hypusinated eIF5A with any treat-
ment. It is possible that even in 3T3-L1 cells treated for an
extended time with (R)-MeSpd, complete depletion of eIF5A was
prevented by a limited metabolism of (R)-MeSpd to (R)-MeSpm
and potentially back to both spermidine and (R)-MeSpd by the
action of SMO. It is also possible that (R)-MeSpd could be used
directly as a substrate for deoxyhypusine synthase more effi-
ciently in mouse 3T3-L1 cells than in human DU145 cells [9].
Nevertheless, our results on two-dimensional gel electrophoresis
showed a clear shift towards the acetylated immature form of
eIF5A in the cells treated with the analogues that did not fully sup-
port differentiation and that also reduced cell proliferation. The
mature hypusinated eIF5A is necessary for cell proliferation, and
reflecting that, only 3 days pre-treatment with (R)-MeSpd in com-
bination with DFMO caused cell death during adipogenesis. Thus,
the impaired synthesis of hypusinated eIF5A in analogue-treated
cells influenced more distinctly proliferation than differentiation.
Our studies revealed for the first time the mechanism by which
DFMO prevents adipogenesis: mRNA levels of key differentiation
transcription factors (PPAR- and C/EBP-.) were markedly
decreased in DFMO-treated cells. As could be expected, the expres-
sion of late adipocyte marker genes (FAS and HSL) was also sup-
pressed. The supplementation of spermidine and MeSpd analogues
restored the expression of all these genes whereas Me2Spm ana-
logues or spermine, especially in the presence of MDL72527, were
not able to support the expression. The fact that the expression lev-
els were lower in cells treated with spermine plus MDL72527 than
in cells treated with spermine alone tends to indicate that the partial
capability of spermine to restore gene expression was due to its
backconversion to spermidine. The down-regulation of HSL in the
cells treated with DFMO and Me2Spm analogues verified that
reduced fat accumulation in these cells was mediated by impaired
adipogenesis and not by increased lipolysis. In addition, our gene
expression results demonstrated that spermidine seems to promote
the expression of PPAR-,  C/EBP-, FAS and HSL. The interaction
of polyamines and especially spermidine with genes involved in
adipocyte metabolism has previously been poorly understood. On
the other hand, it is known that enhanced polyamine catabolism, but
not polyamines themselves, can alter homeostatic control of white
adipose tissue mass through depleting cellular ATP and acetyl-CoA
pools [21, 22]. In the present study we have obtained clear evidence
that spermidine plays an important role in the maintenance of the
expression of some adipocyte specific genes. Whether the mecha-
nism is direct or indirect requires further investigation.
Interestingly, polyamines have also been shown to modulate
the response of adipose tissue-derived stem cells to mechanical
loading [23] and 1,25-dihydroxyvitamin-D3, a stimulant of
osteogenic differentiation [24]. The stem cells responded to these
stimuli with an increase of SSAT gene expression. Whether there
was a consequent induction of SSAT activity leading to changes in
cellular polyamine pools was not reported. However, exogenously
added spermine prevented the bone cell-like responses, such as
nitric oxide production and Cox-2 gene expression, in the former
system [23] but increased the expression of osteogenic differenti-
ation markers, such as runx-2 and osteopontin, in the latter sys-
tem [24]. The findings suggest that polyamines could be used for
manipulation of mesenchymal stem cells towards osteogenic dif-
ferentiation. While adipose tissue-targeted inhibition of polyamine
synthesis could inhibit adipogenesis according to our findings, it
might facilitate osteogenic differentiation of adipose stem cells
through the action of spermine. This should be taken into consid-
eration in designing therapeutic approaches based on modulation
of polyamine metabolism.
In summary, we have demonstrated by using methylated sper-
midine analogues that spermidine is essential for adipogenesis.
Because recruitment of newly formed adipocytes is crucial for the
capability to store excess fat, it is tempting to speculate that the
maintenance of normal polyamine homeostasis and spermidine
concentrations during positive energy intake is critical for the nor-
mal adipose tissue function. In the future, it would be interesting
to investigate spermidine levels in white adipose tissue of obese
patients. However, the present data as such introduce spermidine
as a novel regulator of adipocyte formation and therefore,
polyamine metabolism should be considered as a potential target
pathway for the drug development for obesity.
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